DA Davidson Forecasts Strong Price Appreciation for Clorox (NYSE:CLX) Stock

Clorox (NYSE:CLX) had its price objective raised by DA Davidson from $153.00 to $171.00 in a research report released on Monday morning, Benzinga reports. The brokerage currently has a neutral rating on the stock. DA Davidson also issued estimates for Clorox’s Q2 2025 earnings at $1.27 EPS.

A number of other equities analysts have also weighed in on the company. Deutsche Bank Aktiengesellschaft lifted their price objective on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and upped their price objective for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. TD Cowen assumed coverage on shares of Clorox in a research note on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price objective on the stock. BNP Paribas raised shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. Finally, Barclays raised their price target on shares of Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research report on Friday. Six investment analysts have rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $151.57.

Clorox Trading Down 0.4 %

Clorox stock opened at $162.48 on Monday. Clorox has a 52 week low of $125.46 and a 52 week high of $169.09. The stock has a 50-day moving average price of $161.63 and a 200 day moving average price of $146.33. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The company has a market capitalization of $20.11 billion, a price-to-earnings ratio of 56.61, a price-to-earnings-growth ratio of 3.11 and a beta of 0.41.

Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the firm earned $0.49 EPS. The business’s revenue for the quarter was up 27.0% on a year-over-year basis. Sell-side analysts anticipate that Clorox will post 6.81 EPS for the current year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be paid a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 3.00%. Clorox’s dividend payout ratio (DPR) is currently 170.03%.

Insider Buying and Selling at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.57% of the company’s stock.

Institutional Investors Weigh In On Clorox

A number of large investors have recently modified their holdings of CLX. First Foundation Advisors acquired a new position in Clorox during the first quarter worth about $31,000. Innealta Capital LLC purchased a new position in Clorox in the 2nd quarter worth approximately $30,000. Trifecta Capital Advisors LLC grew its position in shares of Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after purchasing an additional 130 shares in the last quarter. Quarry LP grew its position in shares of Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares in the last quarter. Finally, Family Firm Inc. acquired a new stake in shares of Clorox in the second quarter valued at approximately $31,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.